Invesco Pharmaceuticals ETF Rating $120.37 +0.17 (+0.14%) As of 07/24/2026 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOwnershipRatingsShort InterestBuy This Stock Invesco Pharmaceuticals ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.PJP Aggregate RatingModerate Buy 2.68Holdings in PJP have an aggregate rating of Moderate Buy based on 407 analyst ratings issued in the past year covering 25 companies (92.3% of the portfolio).PJP Aggregate Price Target$120.37High Prediction$120.37Average Prediction$120.37Low Prediction$120.37Holdings in PJP have an aggregate price target of $120.37 and a range of $120.37 to $120.37 covering 25 companies (92.3% of the portfolio).PJP Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy1 Buy rating(s)Moderate Buy19 Moderate Buy rating(s)Hold5 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Invesco Pharmaceuticals ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 PJP Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings5.62%ABBVAbbVie$259.10+0.8%4.3517 of 5 stars2.84$268.10 3.5%25Trending NewsUpcoming EarningsAnalyst Forecast5.30%LLYEli Lilly and Company$1,196.18+0.9%3.7482 of 5 stars2.87$1,283.64 7.3%31Trending News5.29%JNJJohnson & Johnson$263.43+1.6%4.2857 of 5 stars2.80$265.30 0.7%25Trending News5.18%ABTAbbott Laboratories$103.13+2.4%4.7225 of 5 stars2.92$118.61 15.0%26Analyst Downgrade5.12%AMGNAmgen$376.04+1.2%4.0343 of 5 stars2.43$356.62 -5.2%30Positive News4.97%MRKMerck & Co., Inc.$131.06+0.4%4.5312 of 5 stars2.70$133.94 2.2%20Trending NewsOptions Volume4.55%GILDGilead Sciences$129.31-1.2%4.9229 of 5 stars2.86$158.33 22.4%29Analyst Downgrade4.31%PFEPfizer$24.53-1.9%4.2981 of 5 stars2.19$28.50 16.2%21Trending NewsOptions Volume4.01%CORTCorcept Therapeutics$95.36-1.3%2.2498 of 5 stars2.75$88.83 -6.8%8News CoverageUpcoming Earnings3.60%LGNDLigand Pharmaceuticals$300.53-0.5%3.48 of 5 stars2.88$319.00 6.1%8News CoverageAnalyst Forecast3.50%AMRXAmneal Pharmaceuticals$17.92-0.3%1.9587 of 5 stars2.71$16.60 -7.4%7News CoveragePositive News3.48%LQDALiquidia$86.22-3.2%3.3131 of 5 stars2.82$86.18 0.0%11Analyst ForecastOptions VolumeAnalyst Revision3.43%TVTXTravere Therapeutics$57.36+1.2%1.9176 of 5 stars2.69$52.08 -9.2%13News CoveragePositive News3.25%HRMYHarmony Biosciences$35.32-1.3%4.5136 of 5 stars2.50$42.50 20.3%10News CoverageAnalyst Revision3.08%OCULOcular Therapeutix$8.51-1.3%2.4425 of 5 stars2.71$25.11 195.1%142.93%COLLCollegium Pharmaceutical$35.20-1.1%3.0687 of 5 stars3.17$57.50 63.4%6News CoverageAnalyst Downgrade2.90%TARSTarsus Pharmaceuticals$58.66+0.1%3.287 of 5 stars2.78$90.50 54.3%9Analyst Forecast2.85%BIIBBiogen$202.19+0.8%3.9201 of 5 stars2.53$220.57 9.1%32Upcoming EarningsAnalyst Forecast2.76%ANIPANI Pharmaceuticals$77.65-1.1%4.3477 of 5 stars2.67$105.00 35.2%9News CoveragePositive News2.73%VTRSViatris$17.24-0.2%2.5451 of 5 stars2.57$17.50 1.5%7Analyst Upgrade2.72%JAZZJazz Pharmaceuticals$253.87-0.4%2.5255 of 5 stars2.90$259.06 2.0%20News CoveragePositive News2.71%REGNRegeneron Pharmaceuticals$656.01+0.6%4.4539 of 5 stars2.70$787.88 20.1%27Trending NewsUpcoming EarningsAnalyst Forecast2.71%PRGOPerrigo$10.08-0.2%3.926 of 5 stars2.00$19.33 91.9%6Analyst Upgrade2.69%PBHPrestige Consumer Healthcare$49.67+1.5%4.1878 of 5 stars2.00$70.75 42.4%6Positive News2.61%SUPNSupernus Pharmaceuticals$46.20-2.1%4.0409 of 5 stars2.43$62.83 36.0%7News CoveragePositive NewsAnalyst DowngradeShort Interest Decrease This page (NYSEARCA:PJP) was last updated on 7/25/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredSPCX Warning - and Worst News for Stocks in 50 YearsGoldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...TradeSmith | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredElon's new "super startup"Adam O'Dell - the analyst who recommended Palantir before it became the top S&P 500 performer - has identified...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invesco Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Invesco Pharmaceuticals ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
